8 research outputs found

    TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19

    No full text
    Among children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are typically mild. Here, we describe the case of a 3.5-year-old girl with an unusually severe presentation of coronavirus disease (COVID-19). The child had an autoinflammatory disorder of unknown etiology, which had been treated using prednisolone and methotrexate, and her parents were half cousins of Turkish descent. After 5 days of nonspecific viral infection symptoms, tonic-clonic seizures occurred followed by acute cardiac insufficiency, multi-organ insufficiency, and ultimate death. Trio exome sequencing identified a homozygous splice-variant in the gene TBK1, and a homozygous missense variant in the gene TNFRSF13B. Heterozygous deleterious variants in the TBK1 gene have been associated with severe COVID-19, and the variant in the TNFRSF13B gene has been associated with common variable immunodeficiency (CVID). We suggest that the identified variants, the autoinflammatory disorder and its treatment, or a combination of these factors probably predisposed to lethal COVID-19 in the present case

    Towards commercial aquaponics: a review of systems, designs, scales and nomenclature

    No full text
    Aquaponics is rapidly developing as the need for sustainable food production increases and freshwater and phosphorous reserves shrink. Starting from small-scale operations, aquaponics is at the brink of commercialization, attracting investment. Arising from integrated freshwater aquaculture, a variety of methods and system designs has developed that focus either on fish or plant production. Public interest in aquaponics has increased dramatically in recent years, in line with the trend towards more integrated value chains, greater productivity and less harmful environmental impact compared to other production systems. New business models are opening up, with new customers and markets, and with this expansion comes the potential for confusion, misunderstanding and deception. New stakeholders require guidelines and detail concerning the different system designs and their potentials. We provide a definitive definition of aquaponics, where the majority (> 50%) of nutrients sustaining the optimal plant growth derives from waste originating from feeding aquatic organisms, classify the available integrated aquaculture and aquaponics (open, domestic, demonstration, commercial) systems and designs, distinguish four different scales of production (≤ 50, > 50–≤ 100 m2, > 100–≤ 500 m2, > 500 m2) and present a definite nomenclature for aquaponics and aquaponic farming allowing distinctions between the technologies that are in use. This enables authorities, customers, producers and all other stakeholders to distinguish between the various systems, to better understand their potentials and constraints and to set priorities for business and regulations in order to transition RAS or already integrated aquaculture into commercial aquaponic systems

    European contribution to the study of ROS:a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    No full text
    Abstract The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed
    corecore